Updates in Molluscum Contagiosum Management Digital Edition

Selected Abstracts from Maui Derm 2023 for Dermatologists Digital Edition

Natural Hair Supplements: Trends and Myths Untangled Digital Edition

2022 Conference Highlights: Acne

NP+PA PERSPECTIVES IN DERMATOLOGY

2022 Conference Highlights: Acne

NP+PA Perspectives in Dermatology: March 2023

Special Bonus Issue—Dermatology NP & PA Workforce Survey: Practice Characteristics and Compensation

ALL DIGITAL EDITIONS →

Tag: halobetasol

Halobetasol 0.01%/Tazarotene 0.045% Fixed-combination Lotion in the Treatment of Plaque Psoriasis: Sensitization and Irritation Potential

January 1, 2019

J Clin Aesthet Dermatol. 2019;12(1):11–15 by James Q. Del Rosso, DO; Leon Kircik, MD; Tina Lin PharmD; and Radhakrishnan Pillai, PhD Dr. Del Rosso is with JDR Dermatology Research/Thomas Dermatology

Safety and Efficacy of a Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination Lotion in the Treatment of Moderate-to-severe Plaque Psoriasis: A Comparison with Halobetasol Propionate 0.05% Cream

November 1, 2018

J Clin Aesthet Dermatol. 2018;11(11):15–19 by Neal D. Bhatia, MD; David M. Pariser, MD; Leon Kircik, MD; Tina Lin, PharmD; Susan Harris, MS; Lindsey Mathew; and Radhakrishnan Pillai, PhD Dr.